State MD
Clinical Trials in Maryland
Recruiting clinical trials with at least one study location in Maryland. Data updated daily from ClinicalTrials.gov.
Top Conditions in Maryland
NCT00345553 N/A
Recruiting
Biliary Atresia Study in Infants and Children
Condition
Biliary Atresia
Enrollment
1,265 pts
Location
United States, Canada
Sponsor
Arbor Research Collaborative f
NCT03942653 Phase 2
Recruiting
Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen...
Condition
Salivary Gland Carcinoma
Enrollment
20 pts
Location
United States
Sponsor
Manish Patel
NCT06169137 N/A
Recruiting
Pilot Study of Isocaloric Time Restricted Eating on Ketone Metabolism and Immuno...
Condition
Obesity
Enrollment
150 pts
Location
United States
Sponsor
National Institute of Diabetes
NCT04870944 Phase 1, Phase 2
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS ...
Condition
Diffuse Midline Glioma, H3 K27-Altered
Enrollment
63 pts
Location
United States, Australia
Sponsor
Children's Oncology Group
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT04864886 N/A
Recruiting
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Condition
Primary Immunodeficiency
Enrollment
300 pts
Location
United States
Sponsor
National Institute of Allergy
NCT07219966 Phase 3
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disor...
Condition
Alcohol Use Disorder
Enrollment
1,100 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company
NCT07145229 Phase 2
Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Condition
Acute Gouty Arthritis
Enrollment
380 pts
Location
United States, Australia, China
Sponsor
Atom Therapeutics Co., Ltd
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT00004577 N/A
Recruiting
Study of New Magnetic Resonance Imaging Methods of the Brain
Condition
Healthy Volunteer
Enrollment
1,100 pts
Location
United States
Sponsor
National Institute of Neurolog
NCT06990269 Phase 2
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Condition
Geographic Atrophy Secondary to Age-related Macular Degeneration
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
ADARx Pharmaceuticals, Inc.
NCT07128329 Phase 1
Recruiting
Acute Effects of Oral Nicotine Pouches
Condition
Nicotine Pouch Self-Administration
Enrollment
120 pts
Location
United States
Sponsor
Johns Hopkins University
NCT03907475 Phase 2
Recruiting
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced S...
Condition
Locally Advanced Malignant Solid Neoplasm
Enrollment
115 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07221500 Phase 2
Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyr...
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
100 pts
Location
United States, France, Italy
Sponsor
Nurix Therapeutics, Inc.
NCT04699773 N/A
Recruiting
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
Condition
Glioma
Enrollment
32 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT06932341 N/A
Recruiting
Leveraging Electronic Health Record Tools to Improve the Evidence-Based Treatmen...
Condition
Bronchiolitis
Enrollment
800 pts
Location
United States
Sponsor
Johns Hopkins University
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The ...
Condition
Advanced Breast Carcinoma
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
NCT06972459 Phase 3
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight a...
Condition
Obesity
Enrollment
600 pts
Location
United States, Argentina, China
Sponsor
Eli Lilly and Company
NCT05546580 Phase 1
Recruiting
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyr...
Condition
Acute Myeloid Leukemia, in Relapse
Enrollment
50 pts
Location
United States
Sponsor
Oryzon Genomics S.A.
NCT05189262 N/A
Recruiting
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
Condition
Cardiopulmonary Bypass
Enrollment
150 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT06982183 Phase 4
Recruiting
The Effects of Propranolol, Hydrocortisone, and Morphine on Military-Relevant Pe...
Condition
Fear of Spiders
Enrollment
110 pts
Location
United States
Sponsor
Walter Reed Army Institute of
NCT06609083 Phase 1
Recruiting
Effect of Cannabis on Cigarette Use Behavior
Condition
Cannabis Use
Enrollment
100 pts
Location
United States
Sponsor
Johns Hopkins University